均瑶健康5位董高拟减持 公司股价“跌跌不休”

Group 1 - The core point of the article is that Junyao Health (605388.SH) announced a plan for key executives to reduce their holdings of shares due to personal financial needs, which may impact the company's stock performance [2][3]. - The total number of shares to be reduced by the executives is up to 474,900 shares, representing approximately 0.079% of the company's total shares [3]. - This is not the first instance of collective share reduction by Junyao Health's executives, as a similar event occurred in June 2025 [3]. Group 2 - For the first three quarters of 2025, Junyao Health reported revenue of 1.095 billion yuan, a year-on-year decline of 6.95%, and a net profit attributable to shareholders of -2.369 million yuan, a year-on-year decline of 104.79% [3]. - Following the announcement of the executives' share reduction, the stock price of Junyao Health experienced a two-day decline of approximately 4%, with a total market value of around 4.4 billion yuan [4]. - Since the peak in 2023, Junyao Health's stock price has halved, indicating a significant downturn in its market performance [3].